PortfoliosLab logo

Acorda Therapeutics, Inc. (ACOR)

Equity · Currency in USD · Last updated Mar 27, 2023

Share Price Chart


Loading data...

Performance

The chart shows the growth of $10,000 invested in Acorda Therapeutics, Inc. in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $136 for a total return of roughly -98.64%. All prices are adjusted for splits and dividends.


-100.00%-50.00%0.00%50.00%100.00%150.00%200.00%250.00%NovemberDecember2023FebruaryMarch
-98.64%
208.01%
ACOR (Acorda Therapeutics, Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with ACOR

Acorda Therapeutics, Inc.

Return

Acorda Therapeutics, Inc. had a return of -28.57% year-to-date (YTD) and -69.27% in the last 12 months. Over the past 10 years, Acorda Therapeutics, Inc. had an annualized return of -44.02%, while the S&P 500 had an annualized return of 9.86%, indicating that Acorda Therapeutics, Inc. did not perform as well as the benchmark.


PeriodReturnBenchmark
1 month-38.20%-0.66%
Year-To-Date-28.57%3.42%
6 months66.67%5.67%
1 year-69.27%-10.89%
5 years (annualized)-66.87%8.95%
10 years (annualized)-44.02%9.86%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
202323.38%-5.26%
2022-26.83%256.67%-40.19%20.31%

Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Acorda Therapeutics, Inc. Sharpe ratio is -0.32. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-0.90-0.80-0.70-0.60-0.50-0.40-0.30-0.20NovemberDecember2023FebruaryMarch
-0.32
-0.47
ACOR (Acorda Therapeutics, Inc.)
Benchmark (^GSPC)

Dividend History


Acorda Therapeutics, Inc. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%NovemberDecember2023FebruaryMarch
-99.79%
-17.21%
ACOR (Acorda Therapeutics, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the Acorda Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Acorda Therapeutics, Inc. is 99.90%, recorded on Sep 29, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.9%Jan 27, 20151934Sep 29, 2022
-66.96%Feb 13, 2006155Sep 22, 20061Sep 25, 2006156
-55.62%Jul 29, 200882Nov 20, 2008325Mar 11, 2010407
-52.87%May 4, 2010359Oct 3, 2011384Apr 16, 2013743
-37.5%May 8, 200789Sep 12, 200794Jan 28, 2008183
-37.06%Jan 29, 200829Mar 10, 200858Jun 2, 200887
-31.06%Apr 22, 2013181Jan 7, 2014246Dec 29, 2014427
-29.77%Feb 21, 200718Mar 16, 200728Apr 26, 200746
-23.59%Nov 24, 200627Jan 4, 200723Feb 7, 200750
-21.36%Sep 27, 20062Sep 28, 20063Oct 3, 20065

Volatility Chart

Current Acorda Therapeutics, Inc. volatility is 60.41%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%100.00%200.00%300.00%400.00%500.00%600.00%NovemberDecember2023FebruaryMarch
60.41%
19.50%
ACOR (Acorda Therapeutics, Inc.)
Benchmark (^GSPC)